by John Conrad | Aug 5, 2024 | NewsBrief
COUR Pharmaceuticals, a clinical-stage biotech company focused on developing treatments for autoimmune and inflammatory diseases, has announced a significant leadership transition. Founder John J. Puisis will step down as President and Chief Executive Officer, handing...
by John Conrad | Aug 1, 2024 | NewsBrief
A team of researchers at the University of Illinois Urbana-Champaign (UIUC) has made a significant breakthrough in brain imaging technology that could revolutionize the diagnosis and treatment of Alzheimer’s disease. The study, published on July 31, 2024, in ACS...
by John Conrad | Jul 18, 2024 | NewsBrief
GE HealthCare announced today that it has entered into an agreement to acquire the clinical artificial intelligence (AI) software business of Intelligent Ultrasound Group PLC for approximately $51 million. The acquisition aims to integrate innovative AI-driven image...
by John Conrad | Jul 17, 2024 | NewsBrief
A groundbreaking medical device designed to improve breast cancer treatment has successfully completed its first human trial. Innoblative Designs, Inc., a Chicago-based medical device company, announced on July 16, 2024, that its SIRA® RFA Electrosurgical Device was...
by John Conrad | Jul 8, 2024 | NewsBrief
The heart of Illinois is set to become a global leader in biomanufacturing, thanks to a significant $51 million federal grant awarded to the Illinois Fermentation and Agriculture Biomanufacturing (iFAB) Tech Hub. This exciting development promises to transform the...
